Trifecta Capital Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Trifecta Capital Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.31K	Hold	714	–	–	﹤0.01%	239
2025 Q4	$4.48K	Hold	714	–	–	﹤0.01%	244
2025 Q3	$2.13K	Hold	714	–	–	﹤0.01%	329
2025 Q2	$1.36K	Hold	714	–	–	﹤0.01%	394
2025 Q1	$1.04K	Hold	714	–	–	﹤0.01%	370
2024 Q4	$1.32K	Hold	714	–	–	﹤0.01%	348
2024 Q3	$1.69K	Hold	714	–	–	﹤0.01%	332
2024 Q2	$1.96K	Hold	714	–	–	﹤0.01%	316
2024 Q1	$2.98K	Hold	714	–	–	﹤0.01%	264
2023 Q4	$2.31K	Hold	714	–	–	﹤0.01%	311
2023 Q3	$2.14K	Hold	714	–	–	﹤0.01%	301
2023 Q2	$814	Hold	714	–	–	﹤0.01%	386
2023 Q1	$1.19K	Hold	714	–	–	﹤0.01%	355
2022 Q4	$885	Buy	+714	New	+$1.86K	﹤0.01%	384

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trifecta Capital Advisors's ARMP Position: Q1 2026 in Review

Trifecta Capital Advisors held its Armata Pharmaceuticals (ARMP) position steady in Q1 2026 at 714 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #239.

Trifecta Capital Advisors first reported a position in ARMP in Q4 2022 and has held it in 14 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

Trifecta Capital Advisors held 714 shares of Armata Pharmaceuticals worth $7.31K as of Q1 2026.
Trifecta Capital Advisors left its Armata Pharmaceuticals share count unchanged in Q1 2026.
Armata Pharmaceuticals made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q1 2026, its #239 holding.
Trifecta Capital Advisors first reported a position in Armata Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Trifecta Capital Advisors's 13F filing for Q1 2026, filed 1 May 2026.